Precision Biosciences Inc’s recent filing unveils that its Director Buehler Kevin acquired Company’s shares for reported $21122.0 on Mar 26 ’25. In the deal valued at $4.67 per share,4,523 shares were bought. As a result of this transaction, Buehler Kevin now holds 13,235 shares worth roughly $73057.2.
Then, Brown Melinda bought 1,839 shares, generating $8,735 in total proceeds. Upon buying the shares at $4.75, the Director now owns 9,057 shares.
Before that, Germano Geno J bought 3,250 shares. Precision Biosciences Inc shares valued at $17,225 were divested by the Director at a price of $5.30 per share. As a result of the transaction, Germano Geno J now holds 11,057 shares, worth roughly $61034.63999999999.
BMO Capital Markets upgraded its Precision Biosciences Inc [DTIL] rating to an Outperform from a a Market perform in a research note published recently. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in late April with a ‘”a Buy”‘ rating. BMO Capital Markets began covering DTIL with “an Outperform” recommendation on June 17, 2022. William Blair revised its rating on June 09, 2022. It rated DTIL as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of DTIL
On Tuesday, Precision Biosciences Inc [NASDAQ:DTIL] saw its stock jump 23.77% to $5.52. Over the last five days, the stock has gained 19.48%. Precision Biosciences Inc shares have risen nearly 44.88% since the year began. Nevertheless, the stocks have fallen -60.91% over the past one year. While a 52-week high of $14.39 was reached on 01/10/25, a 52-week low of $3.61 was recorded on 01/02/25. SMA at 50 days reached $5.03, while 200 days put it at $7.25.
Levels Of Support And Resistance For DTIL Stock
The 24-hour chart illustrates a support level at 4.92, which if violated will result in even more drops to 4.33. On the upside, there is a resistance level at 5.92. A further resistance level may holdings at 6.33. The Relative Strength Index (RSI) on the 14-day chart is 61.78, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.17, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 12.88%. Stochastics %K at 48.38% indicates the stock is a holding.
How much short interest is there in Precision Biosciences Inc?
A steep rise in short interest was recorded in Precision Biosciences Inc stocks on 2025-03-31, growing by 16052.0 shares to a total of 0.75 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 0.74 million shares. There was a rise of 2.13%, which implies that there is a positive sentiment for the stock.
